Patents Assigned to Neba Health LLC
  • Patent number: 10076279
    Abstract: An EEG headset including an amplifier assembly, a headband assembly formed of a right and a left headband arm and an amplifier platform, a right and left lateral support assembly, at least one hinge assembly connecting at least one of the right or left lateral support assemblies to at least one of the right or left curved arms, and at least one EEG electrode assembly formed of a lead and an electrode. The electrode is in electrical communication with the amplifier assembly via electrical connections within the headset assembly and one of the right and left lateral support assembly.
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: September 18, 2018
    Assignee: Neba Health, LLC
    Inventor: Altan Nahum
  • Publication number: 20140051947
    Abstract: This invention is directed to embodiments of systems and methods to identify a subgroup of ADHD at higher risk for complicating conditions that, for example, may be of concern to an ADHD evaluation, may account for attention and behavior symptoms, and may lead a clinician to exclusion of ADHD from primary diagnosis. In one embodiment, a method for identifying a subgroup of attention deficit hyperactivity disorder (ADHD) patients at higher risk for complicating conditions is provided.
    Type: Application
    Filed: August 12, 2013
    Publication date: February 20, 2014
    Applicant: NEBA HEALTH LLC
    Inventor: Steven M. Snyder
  • Patent number: 8509885
    Abstract: This invention is directed to systems and methods for analyzing depression, and more particularly relates to systems and methods for analyzing and assessing depression and mood disorders in an individual using electroencephalographic measurements. Embodiments of the invention are not limited to depression, but can also include other mood disorders such as bipolar disorder and other disorders with at least one genetic-related component.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: August 13, 2013
    Assignee: Neba Health LLC
    Inventors: Steven M. Snyder, James D. Falk
  • Patent number: 8509884
    Abstract: This invention is directed to embodiments of systems and methods to identify a subgroup of ADHD at higher risk for complicating conditions that, for example, may be of concern to an ADHD evaluation, may account for attention and behavior symptoms, and may lead a clinician to exclusion of ADHD from primary diagnosis. In one embodiment, a method for identifying a subgroup of attention deficit hyperactivity disorder (ADHD) patients at higher risk for complicating conditions is provided.
    Type: Grant
    Filed: August 27, 2010
    Date of Patent: August 13, 2013
    Assignee: Neba Health LLC
    Inventor: Steven M. Snyder
  • Publication number: 20130023783
    Abstract: This invention is directed to systems and methods for analyzing depression, and more particularly relates to systems and methods for analyzing and assessing depression and mood disorders in an individual using electroencephalographic measurements. Embodiments of the invention are not limited to depression, but can also include other mood disorders such as bipolar disorder and other disorders with at least one genetic-related component.
    Type: Application
    Filed: September 26, 2012
    Publication date: January 24, 2013
    Applicant: NEBA HEALTH, LLC
    Inventor: NEBA HEALTH, LLC
  • Patent number: 8311622
    Abstract: This invention is directed to systems and methods for analyzing depression, and more particularly relates to systems and methods for analyzing and assessing depression and mood disorders in an individual using electroencephalographic measurements. Embodiments of the invention are not limited to depression, but can also include other mood disorders such as bipolar disorder and other disorders with at least one genetic-related component.
    Type: Grant
    Filed: November 30, 2006
    Date of Patent: November 13, 2012
    Assignee: Neba Health LLC
    Inventors: Steven M. Snyder, James D. Falk